RYAN HOLCOMB: Open Payments
NPI 1265832265 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,329 in 80 payments from 13 companies in 2025. Trend: 2023 $989 · 2024 $1,193 · 2025 $1,329
Food & beverage: $1,144Education: $185
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $318 |
| Incyte Corporation | 25 | $301 |
| UCB, Inc. | 9 | $191 |
| Amgen Inc. | 6 | $94 |
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| Lilly USA, LLC | 4 | $85 |
| GENZYME CORPORATION | 4 | $67 |
| ABBVIE INC. | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 3 | $45 |
| Organon LLC | 3 | $35 |
Products named: TREMFYA, OPZELURA, Bimzelx, Otezla, DUPIXENT, TALTZ, COSENTYX, Sotyktu.
Industry payments across NM — which companies pay providers there.
